α-Amylase/α-Glucosidase-IN-8

α-Amylase/α-Glucosidase-IN-8

Cat. No.: DIA-0243294

Size: 50 mg Size: 100 mg Size: 250 mg Size: Customer Size
Product Information
Formula C19H16N2O6S
Molecular Weight 400.41
SMILES O=C(N(CC1=CC=CC([N+]([O-])=O)=C1)C/2=O)SC2=C/C3=CC=C(O)C(OCC)=C3
Target Amylases, Glucosidase
Product Description α-Amylase/α-Glucosidase-IN-8 (Compound 7p) is a potent dual inhibitor of α-amylase and α-glucosidase, with IC50s of 10.19 and 10.33 μM, respectively. α-Amylase/α-Glucosidase-IN-8 has good anti-oxidant activity(IC50 = 14.93 μM). α-Amylase/α-Glucosidase-IN-8 can be used for the research of diabetes.
Format & Storage
Shipping Room temperature in the continental U.S. Other areas may vary.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top